Abstract
Background: Alzheimer's disease (AD) diagnosis heavily relies on amyloid-betapositron emission tomography (Abeta-PET), which is limited by high cost andlimited accessibility. This study explores whether Abeta-PET spatial patternscan be predicted from blood-based biomarkers (BBMs) and MRI scans. Methods: Wecollected Abeta-PET images, T1-weighted MRI scans, and BBMs from 566participants. A language-enhanced generative model, driven by a large languagemodel (LLM) and multimodal information fusion, was developed to synthesize PETimages. Synthesized images were evaluated for image quality, diagnosticconsistency, and clinical applicability within a fully automated diagnosticpipeline. Findings: The synthetic PET images closely resemble real PET scans inboth structural details (SSIM = 0.920 +/- 0.003) and regional patterns(Pearson's r = 0.955 +/- 0.007). Diagnostic outcomes using synthetic PET showhigh agreement with real PET-based diagnoses (accuracy = 0.80). Using syntheticPET, we developed a fully automatic AD diagnostic pipeline integrating PETsynthesis and classification. The synthetic PET-based model (AUC = 0.78)outperforms T1-based (AUC = 0.68) and BBM-based (AUC = 0.73) models, whilecombining synthetic PET and BBMs further improved performance (AUC = 0.79).Ablation analysis supports the advantages of LLM integration and promptengineering. Interpretation: Our language-enhanced generative model synthesizesrealistic PET images, enhancing the utility of MRI and BBMs for Abeta spatialpattern assessment and improving the diagnostic workflow for Alzheimer'sdisease.